Association of C-peptide and leptin with prostate cancer incidence in the Health Professionals Follow-up Study

Association Between Prediagnostic Biomarkers of Inflammation and Endothelial Function and Cancer Risk: A Nested Case-Control Study

(2012) M. Touvier et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Associations of adiponectin and leptin with stage and grade of PSA-detected prostate cancer: the ProtecT study

(2012) Anya Burton et al.   CANCER CAUSES & CONTROL

Association between biomarkers of obesity and risk of high-grade prostatic intraepithelial neoplasia and prostate cancer – Evidence of effect modification by prostate size

(2012) Jay H. Fowke et al.   CANCER LETTERS

Effect of Elevated Basal Insulin on Cancer Incidence and Mortality in Cancer Incident Patients: The Israel GOH 29-year follow-up study

(2012) R. Dankner et al.   DIABETES CARE

A higher prediagnostic insulin level is a prospective risk factor for incident prostate cancer

(2010) J. Hammarsten et al.   Cancer Epidemiology

Finasteride Modifies the Relation between Serum C-Peptide and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial

(2010) M. L. Neuhouser et al.   Cancer Prevention Research

Association between C-Peptide Concentration and Prostate Cancer Incidence in the CLUE II Cohort Study

(2010) G. Y. Lai et al.   Cancer Prevention Research

Association Between Plasma Leptin Levels and Diabetes Mellitus

(2010) Pavani Bandaru et al.   Metabolic Syndrome and Related Disorders

A 25-Year Prospective Study of Plasma Adiponectin and Leptin Concentrations and Prostate Cancer Risk and Survival

(2009) H. Li et al.   CLINICAL CHEMISTRY

Risk factors for prostate cancer

(2009) Amit R Patel et al.   Nature clinical practice. Urology

Association between plasma cholesterol and prostate cancer in the PSA era

(2008) Elizabeth A. Platz et al.   INTERNATIONAL JOURNAL OF CANCER

Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis

(2008) Jing Ma et al.   LANCET ONCOLOGY